Quantcast
Last updated on April 24, 2014 at 16:01 EDT

Latest proteomics Stories

2013-07-08 12:16:08

University of Toronto researchers are helping demystify an important class of proteins associated with disease, a discovery that could lead to better treatments for cancer, cystic fibrosis and many other conditions. Igor Stagljar, Professor in the Faculty of Medicine's Donnelly Centre for Cellular and Biomolecular Research, and his team developed the first roadmap for ATP-binding cassette (ABC) transporter proteins. These proteins are crucial components of every cell, and are also involved...

2013-07-07 23:00:58

RnRMarketResearch.com adds Latest Report on “Analysis of Global Biochips Industry, 2012-2018” to its store. Dallas, TX (PRWEB) July 07, 2013 Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally....

2013-07-02 14:00:06

Neurodegenerative diseases such as Alzheimer's could be better understood thanks to insight into proteins linked to such conditions, a study suggests. Scientists studying thread-like chains of protein – called amyloid fibers – have found that low levels of these proteins may cause more harm to health than high levels. These rarely formed protein chains, which have been linked with dozens of diseases, are produced as a result of a genetic flaw or...

2013-07-01 08:25:55

SANTA CLARA, Calif., July 1, 2013 /PRNewswire/ -- ProteinSimple today released version 2.4 of Compass Software, which runs its Simple Western instruments complete with CFR Title 21 Part 11 compliance tools. With this software release, not only has ProteinSimple fully redesigned the age-old traditional Western and replaced it with a fully automated, fully quantitative platform, it has now enabled researchers to quickly and easily validate assays run on these systems to meet the...

2013-06-26 12:32:34

DUBLIN, June 26, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/c3dxhc/proteomics) has announced the addition of Jain PharmaBiotech's new report "Proteomics - Technologies, Markets and Companies [http://www.researchandmarkets.com/research/c3dxhc/proteomics ]" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes and evaluates the proteomic technologies that will play an...

2013-06-26 08:28:29

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, June 26, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Life Technologies Corporation (NASDAQ: LIFE), Thermo Fisher Scientific, Inc. (NYSE: TMO), Agilent Technologies Inc. (NYSE: A), Quest Diagnostics Inc. (NYSE: DGX) and PerkinElmer Inc. (NYSE: PKI). Today's readers may access these reports free of charge - including full price targets, industry...

2013-06-21 23:20:27

Spectra QEST is the SA State iAwards Winner in the Industrial Category. This award honours Spectra QEST for its creation of the innovative QEST Quality Platform, a suite of software products that facilitates substantial improvement in efficiency, quality and standardisation of construction materials testing processes. (PRWEB) June 21, 2013 The iAwards recognises companies at the cutting edge of technology innovation and is “the premier technology awards platform in Australia delivering...

2013-06-12 08:27:42

New open-access website also documents over 250,000 predicted protein kinase drug interactions using proprietary algorithms VANCOUVER, June 12, 2013 /PRNewswire/ - Kinexus Bioinformatics Corporation, a world-leader in the study of molecular intelligence systems, announced the launch of its DrugKiNET KnowledgeBase (www.drugkinet.ca) for the identification and development of drug candidates that potently and selectively inhibit human protein kinases. This open-access website...

2013-06-10 23:02:08

Shimadzu Announces New MALDI-7090 Mass Spectrometer Columbia, MD (PRWEB) June 10, 2013 Shimadzu introduces the new MALDI-7090 MALDI TOF-TOF mass spectrometer targeted for proteomics and tissue imaging research. The combination of Shimadzu´s extensive MALDI TOF-TOF expertise with novel patented technology provides the MALDI-7090 with ultimate capabilities for identification and structural characterization of biomolecules. Innovative technology incorporated into the MALDI-7090, such as...

2013-05-28 23:01:40

The global central nervous system (CNS) biomarker market is projected to reach nearly $5.1 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 20.7%. This aggressive growth rate is driven by several factors, including the increase in public-private partnerships with government support, pressure to keep healthcare costs down, an increasing elderly population, and the rapid advancement of genomic and proteomic technologies, which have impacted the CNS...